🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Pennsylvania › Philadelphia

Etid klinik pou Kansè (tout kalite) nan Philadelphia, PA

59 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Autoimmunity After Checkpoint Blockade

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT04119713

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07277270

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 4021), Philadelphia
1 Month – 17 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07630974

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06150157

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • GSK Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07438782

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Ap rekriteFaz 3
  • Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100), Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07405164

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Ap rekriteFaz 2
  • Fox Chase Cancer Center, Philadelphia
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Ap rekriteFaz 2/3
  • University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University - Clinical Research Institute, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia
1 Month – 17 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06941272

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Ap rekriteFaz 2
  • University of Pennsylvania, Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
  • USO - Alliance Cancer Specialists, PC, Horsham · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06163534

Lurbinectedin in FET-Fused Tumors

Ap rekriteFaz 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640

IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer

Ap rekriteEtid obsèvasyon
  • Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06206941

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Drexel University School of Medicine, Philadelphia
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • ak 1 plis
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Ap rekriteFaz 3
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05335928

Indirect Calorimetry-Guided Parenteral Nutrition Prescribing in Oncology Patients

Ap rekrite
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07776704

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Perelman School of Medicine, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Pennsylvania Hospital, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
  • ak 5 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 1 a 26 · Tout sèks · Mizajou Aug 4, 2026 · NCT07680439

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 2 a 25 · Tout sèks · Mizajou Jul 24, 2026 · NCT06458036

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

Ap rekriteVolontè an sante akeyi
  • Nemours Children's Health, Delaware, Wilmington · 25 mi lwen
Tout laj · Tout sèks · Mizajou Jul 17, 2026 · NCT05294302

Evaluation of Grief Therapy Approaches for Bereaved Parents

Ap rekrite
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jul 1, 2026 · NCT05142605

Molecular Genetics Studies of Cancer Patients and Their Relatives

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Paoli Memorial Hospital, Paoli · 18 mi lwen
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935

Childhood Cancer Survivor Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Children's Hospital of Philadelphia, Philadelphia
Tout laj · Tout sèks · Mizajou Jun 17, 2026 · NCT01120353

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Ap rekrite
  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Laj 18 a 75 · Tout sèks · Mizajou Jun 17, 2026 · NCT05486572

Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)

Ap rekrite
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Fanm · Mizajou Jun 12, 2026 · NCT07454499

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Ap rekriteFaz 1
  • University of Pennsylvania, Philadelphia
  • Context Investigational Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT06756035

Synovial Sarcoma Registry / Biospecimen Repository

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Tout laj · Tout sèks · Mizajou Jun 9, 2026 · NCT05910307

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Ap rekrite
  • Albert Einstein Healthcare Network, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT03245411

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT03686124

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Ap rekriteFaz 2
  • University of Pennsylvania (U Penn), Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT01042379

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 16, 2026 · NCT06959706

Massage Impact on Sleep in Pediatric Oncology

Ap rekrite
  • Children's Hospital of Philadelphia, Philadelphia
Laj 12 a 21 · Tout sèks · Mizajou Apr 15, 2026 · NCT06892158

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 20, 2026 · NCT05948865

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Ap rekriteFaz 2
  • Shields and Shields, PC, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT06643884

Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT07471958

TumorGlow Intraoperative Molecular Imaging (IMI)

Ap rekriteFaz 1/2
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 9, 2026 · NCT04723810

The Radiation Oncology Registry and Biosample Repository

Ap rekriteEtid obsèvasyon
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 4, 2026 · NCT01577251

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Ap rekriteFaz 1/2
  • University of Pennsylvania, Abramson Cancer Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT06014658

Re-Engaging AYA Survivors in Cancer-Related Healthcare

Ap rekrite
  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Medicine, Philadelphia
Laj 15 a 29 · Tout sèks · Mizajou Feb 18, 2026 · NCT07138040

From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

Ap rekriteEtid obsèvasyon
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT07352579

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

Ap rekriteFaz 2
  • Pennsylvania Oncology Hematolo /ID# 249637, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT04895436

eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer

Ap rekriteVolontè an sante akeyi
  • Abramson Cancer Center at the University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT05427240

CARE Study: Cancer, Asian Americans, and Relationship Enrichment

Ap rekriteVolontè an sante akeyi
  • Fox Chase Cancer Center - Philadelphia, Philadelphia
Laj 21 a 80 · Tout sèks · Mizajou Dec 31, 2025 · NCT06782581

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Laj 0 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05024929

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Ap rekriteFaz 2
  • Children's Hospital of Philadelphia, Philadelphia
Laj 2 a 99 · Tout sèks · Mizajou Nov 14, 2025 · NCT05783323

Cannabis Use and Outcomes in Black and White Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Thomas Jefferson University, Philadelphia
  • University of Pennsylvania, Philadelphia
Laj 21 a 99 · Tout sèks · Mizajou Oct 30, 2025 · NCT06037681

Childhood Cancer Predisposition Study (CCPS)

Ap rekriteEtid obsèvasyon
  • Children's Hospital of Philadelphia, Philadelphia
Tout laj · Tout sèks · Mizajou Oct 29, 2025 · NCT04511806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Philadelphia
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Lankenau Medical Center, Paoli · 18 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Oct 20, 2025 · NCT06877884

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • Fox Chase Cancer Center, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

Ap rekriteFaz 3
  • Perelman Center for Advanced Medicine, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2024 · NCT03659448

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.